
<DOC>
<DOCNO>WT03-B24-178</DOCNO>
<DOCOLDNO>IA064-000378-B004-267</DOCOLDNO>
<DOCHDR>
http://www.sosei.com:80/BioCentury2/library/allpart/allpartk.htm 206.86.52.80 19970112095858 text/html 5309
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 09:58:52 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 5127
Last-modified: Thu, 26 Sep 1996 23:59:23 GMT
</DOCHDR>

<HTML>
<BODY background = "../../graphics/white-mi.gif">
<HEAD><TITLE> Alliances & Partnering</TITLE></HEAD>

<H1><CENTER>'ñŒg‚Æƒp?[ƒgƒi?[ƒVƒbƒv</H1></CENTER><P>

<B><A HREF="/BioCentury2/archive/1996/1qtr/031996ex.htm">Athenaé-ÅEElané-çáï¼ÇÃîwå"</A></B><br>
Ç±ÇÃãLéñÇÕÅAÉAÉeÉiÅEÉjÉÖÅ[ÉçÉTÉCÉGÉìÉXé-Ç?ÉGÉâÉìé-ÇÃçáï¼ÇÃîwå"ä÷åWÇŠÇ¬Ç¢ÇŸêı
ñæÇµÇŸÇ¢ÇĞÇ…ÅB1996îN3åé19ì™(1,220 åÍ).<P>

<B><A HREF ="/BioCentury2/archive/1996/1qtr/011596a1.htm"> ‹Z?p'ñŒg </A></B><BR>
‚±‚Ì‹L–‚Í?A‰¢•Ä‚Å'ä"ª‚µ‚Â‚Â‚ ‚é‹Z?p‚Æ"ú–{‚Ì‹¤"¯‰ï-‚ğŒ‹‚-•t‚¯‚é‚Æ‚¢‚¤Sosei Co. Ltd.‚ª—p‚¢‚Ä‚¢‚é?V‚µ‚¢ƒAƒvƒ??[ƒ`‚ğ?à–¾‚µ‚Ä‚¢‚Ü‚·?B1996"N1Œ15"ú (1,900 Œê)?B <p>

‰º‹L‚Ì—v–ñ‚Í?AŠe‰pŒê‚ÌŒ´•¶‚É'¼?Ú‚ÉƒŠƒ"ƒN‚³‚ê‚Ä‚¢‚Ü‚·?B<P>
<B><A HREF ="/BioCentury2/archive/1995/4qtr/1113a1.htm">
ArrisÇ?KhepriÇ?Ç¢Ç©ÇŠÇµÇŸçáï¼ÇŠíBÇµÇ‡Ç©</A></B><BR>
åvâÊÇ„ÇÍÇŸÇ¢ÇÈKhepri Pharmaceuticals Inc.Ç?Arris Pharmaceutical Corp. ÇÃçáï¼ÇÕÅAèâä™ÇİÇÈÇ¢ÇÕíÜä™ÇÃíiäKÇŠÇ¢Ç‡Ç¡ÇŸÇ¢ÇÈÉoÉCÉIÉeÉNÉmÉçÉWÅ[äÈã?Ç?íºñ ÇµÇŸÇ¢ÇÈèdóvÇ»ñ'ëËÇ•î‡âfÇµÇŸÇ¢ÇĞÇ…ÅBÇ±ÇÃãLéñÇÕÅAÇ±ÇÃìÒé-Ç?ÉvÉgÉeÉCÉYÇ•ÉxÅ[ÉXÇŠÇµÇ‡ñÚïiÇÃÉvÉçÉOÉâÉÄÇ•çáï¼ÇµÇÊÇ§Ç?åàífÇµÇ‡Ç?Ç´ÇŠÇ«ÇÃÇÊÇ§Ç»ãZèpäJî‚ÅAéëãıí¾íBÇ'äÈâÊêÌó?Ç•çló?ÇµÇ‡Ç©Ç•êıñæÇµÇŸÇ¢ÇĞÇ…ÅB 1995îN11åé13ì™ (3,100 åÍ)
<P>

<B><A HREF ="/BioCentury2/archive/1995/4qtr/1023a1.htm">äÿçëÇŠÇ®ÇØÇÈÉpÅ[ÉgÉiÅ[ä÷åW</A></B><BR>
ì™ñ{ÇÃå¸Ç±Ç§ÇŠñÇ•å¸ÇØÇŸñkïŸÇ'â¢èBÇÃäÈã?ÇÕÅAäÿçëÇ•ÉoÉCÉIÉeÉbÉNä÷åWÇÃÉpÅ[ÉgÉiÅ[ÉVÉbÉvÇ•åãÇ'ÇÃÇŠÉ|ÉeÉìÉVÉÉÉãÇ•éùÇ¡Ç‡ñ£óÕìIÇ»Ç?Ç±ÇÎÇ?ÇµÇŸå©ÇŸÇ¢ÇÈÇÊÇ§Ç‰Ç…ÅB
Ç±ÇÃãLéñÇÕÅA AvironÇ?Neoprobe Corp. Ç?äÿçëÇ‰ç\ízÇµÇ‡íÒågä÷åWÇ•èqÇ×ÇŸÇ¢ÇĞÇ…ÅBÉoÉCÉIÉeÉbÉNäÈã?Ç?éÊà¯ÇÃëOÇŠÅAÇ¢Ç©ÇŠäÿçëésèÍÇÃì?ì¡Ç»ó•éjÇ'ÇªÇÃÉrÉWÉlÉXÇÃèKäµÇ•ÇĞÇ»Ç'ÇÀÇ'Ç»ÇÁÇ»Ç¢Ç©Ç?Ç¢Ç§å©â•Ç•èqÇ×ÇŸÇ¢ÇĞÇ…ÅB Oct. 23, 1995 (3250 words)

<B><A HREF ="/BioCentury2/archive/1995/3qtr/0918a1.htm">Šó–]"IŠÏ'ª</A></B><BR>
Šé‹Æ'ñŒg‚Ì?ó‹µ‚Æ"Š'Ò‚Ì—v‹?‚Ì'Î—§‚ÉƒvƒŒƒbƒVƒƒ?[‚ğŠ´‚¶?AƒoƒCƒIƒeƒNƒmƒ?ƒW?[Šé‹Æ‚ªƒ}?[ƒPƒbƒg?EƒTƒCƒY‚Ì—\'ª‚ğ‚Å‚«‚é‚¾‚¯'å‚«‚­Œ©?Ï‚à‚Á‚Ä‚¢‚éŒXŒü‚ªŒ©ó‚¯‚ç‚ê‚Ü‚·?B‚±‚Ì‹L–‚Í?A‚±‚Ì‚æ‚¤‚È–â'è‚ªƒp?[ƒgƒi?[ƒVƒbƒv?¬—§‚ğ‚Ç‚Ì‚æ‚¤‚É?¶‰E‚·‚é‚©‚ğ•ª?Í‚µ‚Ä‚¢‚Ü‚·?B1995"N9Œ18"ú (3,350 Œê)<P>


<B><A HREF="/BioCentury2/archive/1995/2qtr/0626a1.htm">Amylin's New Deal?iAmylin‚Ì?V'ñŒg?j</A></B><BR>
Amylin Pharmaceuticals Inc.‚ªƒpƒgƒi?[‚ğŠ·‚¦‚é‹L–‚Å?A"œ"A•aŠÖŒW‚Ì?»•i‚Å‚ ‚éAC137 amylin agonist compound‚ğŒ±‚Ì'æ"ñ'iŠK‚©‚ç?»•i"­"„‚Ü‚Å‚Ì‰ÈŠw"I‚©‚ÂŒo?Ï"I‚ÈƒŠƒXƒN‚ğƒJƒo?[‚·‚é‚½‚ß‚É Johnson & Johnson‚Æ'ñŒg‚µ‚Ü‚µ‚½?B Glaxo-Wellcome‚Í?A‚à‚Í‚â‰ÈŠw"IŠJ"­‚©‚çè‚ğˆø‚«‚Ü‚µ‚½‚ª?AŒ»?İAmylin‚ÌŠ"‚ğ?Š—L‚µ‚Ä‚¢‚Ü‚·?B26.6.95 (1870Œê)<P>

<B><A HREF="/BioCentury2/archive/1995/2qtr/0605a1.htm">Pharma Partners for Biotech?iƒoƒCƒeƒbƒN‚Ì?»–ò‚Ìƒpƒgƒi?[Œó•â?j</A></B><BR>
?»–ò‰ïĞ‚Ìƒgƒbƒv?Eƒ}ƒl?[ƒWƒ?ƒ"ƒg‚ªƒoƒCƒIƒeƒNƒmƒ?ƒW?[‚Ìƒpƒgƒi?[Œó•â‚É‹?‚ß‚Ä‚¢‚é‹L–‚Å‚·?B‚»‚ÌŒ®‚Í‚Ü‚¸‰ÈŠw?A‚»‚µ‚Ä‚»‚ÌŸ‚É'm"I?Š—LŒ ‚ª'å?Ø‚Å‚·?B‚±‚ê‚ÆŠÖŒW‚µ‚Ä‚¢‚é‚à‚Ì‚Å?A<A HREF="../../archive/1995/2qtr/0605a4.htm>Explaining Valuations </A>‚Æ‚¢‚¤‹L–‚Å‚Í?»–ò‰ïĞ‚Ìæ‚èˆø‚«‰¿Ši‚ÆŠ""­?s‚Ì‰¿Ši‚Ì'Šˆá‚ğ?à–¾‚µ‚Ä‚¢‚Ü‚·?B5.6.95 (650Œê)<P>

<B><A HREF="/BioCentury2/archive/1995/2qtr/0522b1.htm">Aviron Finds Korean Partner?iAviron‚ÍŠØ?'‚Ìƒpƒgƒi?[‚ğŒ©‚Â‚¯‚é?j</A></B><BR>
‚±‚Ì‹L–‚Å‚Í?A Aviron ‚ªƒnƒ"ƒ{?[?EƒOƒ‹?[ƒv‚Ìƒ?ƒ"ƒo?[‚Å‚ ‚éSang-A‚Æ‚¢‚¤ŠØ?'‚Ì?»–ò‰ïĞ‚Æ'ñŒg‚·‚éˆÓ–¡‚ª?à–¾‚³‚ê‚Ä‚¢‚Ü‚·?B?v'¬‚ÉŒˆ'è‚µ‚½'ñŒg‚¾‚Á‚½‚½‚ß?Aƒ?ƒNƒ`ƒ"Šé‹Æ‚ªƒpƒgƒi?[‚ğ'T‚·"ÍˆÍ‚ªˆê"x‚É?L‚­‚È‚Á‚½Œ‹‰Ê‚Æ‚È‚è‚Ü‚µ‚½?B22.5.95 (750Œê)<P>

<B>Chiron's Gene Therapy Efforts?iChiron‚Ìˆâ"`q¡—ÃŠˆ"®?j</B><BR>
‚±‚Ì"ñ‚Â‚Ì‹L–‚Í?A Chiron‚ªˆâ"`q¡—Ãƒvƒ?ƒOƒ‰ƒ€‚ğ?ì‚è?ã‚°‚é"®‚«‚ğ?à–¾‚µ‚Ä‚¢‚Ü‚·?Bˆê‚Â–Ú‚Í?A Chiron‚ª<A HREF="/BioCentury2/archive/1995/2qtr/0410b1.htm">Progenitor Inc.‚Ì</A>"ñƒEƒCƒ‹ƒX?ˆ—?‹y‚ÑƒGƒNƒXƒvƒŒƒbƒVƒIƒ"?EƒVƒXƒeƒ€‚ğ—˜—p‚·‚é‹L–‚Å‚·?B10.4.95 (550Œê)<P>

"ñ‚Â–Ú‚Í?A Chiron‚ª<A HREF="/BioCentury2/archive/1995/2qtr/0425a1.htm">Viagene Inc.</A>‚ğ"ƒû‚·‚é?ğŒ?‚âˆÓ–¡‚ğ˜_‹c‚·‚é‹L–‚Å‚·?B25.4.95 (1250Œê)<P>

<B><A HREF ="/BioCentury2/archive/1995/1qtr/0306a3.htm">Isis: The Power Positioning Deal?iIsis?Fƒpƒ??[‹­‰»‚ğ'_‚¤'ñŒg?j</A></B><BR>

‰Š?Ç•a‚É—Í‚ğ"ü‚ê‚é‚½‚ß‚ÉIsis Pharmaceuticals Inc.‚ÆBoehringer Ingelheim International Gmbh‚ª‚»‚ê‚»‚ê‚ÌŒ¤‹†ŠJ"­ƒvƒ?ƒOƒ‰ƒ€‚ğ"??‡‚·‚é•ª?ÍŒŸ"¢‚ğ‚·‚é‹L–‚Å‚·?B‚±‚ÌŒ®‚Í?A'½—l‚È‹Z?p‚ğ"??‡‚·‚é‚±‚Æ?A‚Ü‚½‚Í?A•a‹CŒo‰c‚Ìƒ|?[ƒgƒtƒHƒŠƒI‚ğ‚Â‚­‚é‚±‚Æ‚Å‚·?B 6.3.95 (1300Œê)<P>

<B><A HREF="/BioCentury2/archive/1995/1qtr/0213a1.htm">Reasons to Take Over Amgen?iAmgen‚ª"ƒû‚³‚ê‚é—?—R?j</A></B><BR>

?æ‚Áæ‚è‚Ì‰\‚Å?A Amgen‚ÌŠ"‚Ì"„"ƒ‚ªŠˆ"­‚¾‚Á‚½ˆê?TŠÔ‚É'Î‚µ‚Ä?AƒEƒI?[ƒ‹ŠX‚Ì—L?"‚È•ª?ÍÒ˜Z?l‚ª"½‰‚ğ?q‚×‚Ä‚¢‚é‹L–‚Å‚·?B"ƒû‚·‚é'¤‹y‚Ñ Amgen‚ÌŠ"å‚É‚Æ‚Á‚Äæ‚èˆø‚«‚ÌƒRƒXƒg‚ªƒ?ƒŠƒbƒg‚ğ'´‚·‚Ì‚Å‚Í‚È‚¢‚©‚Æ‹c˜_‚µ‚Ä‚¢‚Ü‚·?B13.2.95 (1900Œê)<P>

<H5><HR>

<A HREF="http://www.sosei.com/"><IMG  Align=Middle Border =0
SRC="http://www.sosei.com/Graphics/home_button.gif">BioGlobe Home Page</A>
<A HREF="http://www.sosei.com/BioCentury2/kanjipg.htm"><IMG  Align=Middle Border =0
SRC="http://www.sosei.com/BioCentury2/graphics/bc_button.gif">BioCentury Home Page</A>

<HR>

Copyright (c) 1995 BioCentury Publications Inc. ALL RIGHTS RESERVED.<P>

BioCentury, The BioCentury 100 and The Clear Route to ROI are trade marks of BioCentury Publications Inc. All other trade marks are the property of their respective owners. </H5><P>

</BODY></HTML>

</DOC>